Upstate Active Clinical Trials
Study Title:Outcomes of Autism Treatment Using Naltrexone
What is the purpose of the study?The purpose of this study is to collect information from the patients we treat for autism spectrum disorders in order to evaluate our treatment methods and report the outcomes of our treatment approaches in medical journals.
Upstate Institutional Review Board (IRB) Number:721816
Patient Age Group:Adults
Principal Investigator:Brian Johnson
Who can I contact for more information?
Name: Jacqueline M Hattersley